Antitumor Effects of L6, an IgG2a Antibody that Reacts with Most Human Carcinomas

Mouse monoclonal antibody L6 (IgG2a sub-type) recognizes a ganglioside antigen expressed at the surface of cells from human non-small-cell lung carcinomas, breast carcinomas, and colon carcinomas. We now show that this antibody can lyse L6 antigen-positive human tumor cells in the presence of Leu-11...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 83; no. 18; pp. 7059 - 7063
Main Authors Hellström, Ingegerd, Beaumier, Paul L., Hellström, Karl Erik
Format Journal Article
LanguageEnglish
Published Washington, DC National Academy of Sciences of the United States of America 01.09.1986
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mouse monoclonal antibody L6 (IgG2a sub-type) recognizes a ganglioside antigen expressed at the surface of cells from human non-small-cell lung carcinomas, breast carcinomas, and colon carcinomas. We now show that this antibody can lyse L6 antigen-positive human tumor cells in the presence of Leu-11b-positive human lymphocytes (i.e., mediate antibody-dependent cellular cytotoxicity) or human serum (mediate complement-dependent cytotoxicity) and that it can inhibit the outgrowth of an L6 antigen-positive human tumor transplanted onto nude mice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.83.18.7059